SELPLG and pancreatic neoplasm: Pancreatic cancer cell-derived T-EVs containing active TFs and P-selectin glycoprotein ligand 1 (SELPLG) have been revealed to accumulate at locations of impairment, reducing haemorrhage upon injection into living mice [123].